Related Experiment Video
Updated: Jul 19, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
[Probiotics in chronic inflammatory bowel disease].
MMW Fortschritte Der Medizin
|September 26, 2006
Summary
Probiotics like E. coli Nissle 1917 and VSL#3 show strong evidence in preventing inflammatory disease recurrence, particularly ulcerative colitis remission and pouchitis prevention. These findings support their use in maintaining remission and preventing post-surgical complications.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Probiotics demonstrate greater efficacy in preventing the recurrence of inflammatory conditions than in treating active disease.
- Established evidence supports the use of specific probiotic strains for maintaining remission in inflammatory bowel diseases.
Purpose of the Study:
- To summarize current data on probiotic efficacy in preventing inflammatory disease recrudescence.
- To highlight the role of specific probiotics in maintaining remission and preventing post-operative complications.
Main Methods:
- Review of current clinical data and guidelines regarding probiotic use in inflammatory bowel disease.
- Analysis of evidence for specific probiotic strains, including E. coli Nissle 1917 and VSL#3.
Main Results:
- Strong evidence exists for E. coli Nissle 1917 (Mutaflor) in maintaining ulcerative colitis remission.
- VSL#3 is effective in preventing the recurrence of pouchitis and shows promise in preventing pouchitis post-proctocolectomy.
- These applications are reflected in current clinical guidelines.
Conclusions:
- Probiotics are more effective for preventing inflammatory disease recurrence than for active disease suppression.
- Specific probiotic formulations are valuable tools for managing inflammatory bowel diseases and preventing post-surgical inflammation.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...